Veracyte
VCYT
#4274
Rank
โ‚น238.41 B
Marketcap
โ‚น3,001
Share price
0.00%
Change (1 day)
18.80%
Change (1 year)

Revenue for Veracyte (VCYT)

Revenue in 2025 (TTM): โ‚น45.28 Billion

According to Veracyte's latest financial reports the company's current revenue (TTM ) is โ‚น48.11 Billion. an increase over the revenue in the year 2024 that were of โ‚น38.24 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Veracyte from 2013 to 2025

Annual revenue

Year Revenue Change
2025 โ‚น46.42 B21.4%
2024 โ‚น38.24 B27.23%
2023 โ‚น30.05 B22.49%
2022 โ‚น24.53 B50.19%
2021 โ‚น16.33 B90.16%
2020 โ‚น8.59 B0.1%
2019 โ‚น8.58 B33.42%
2018 โ‚น6.43 B40.03%
2017 โ‚น4.59 B3.88%
2016 โ‚น4.42 B34.44%
2015 โ‚น3.28 B35.92%
2014 โ‚น2.42 B79.02%
2013 โ‚น1.35 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Exact Sciences
EXAS
โ‚น302.09 B 527.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
โ‚น76.78 B 59.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-โ‚น0.32 Billion-100.66%๐Ÿ‡บ๐Ÿ‡ธ USA